Immune Response CC Chemokines, CCL5 and CCL2 Are Associated with Pulmonary Sarcoidosis.

被引：0
|
作者：
Hashemi, N. [1 ]
Weigt, S. S. [1 ]
Xue, Y. Y. [1 ]
Palchevskiy, V. [1 ]
Huang, C. [1 ]
Zisman, D. A. [1 ]
Fishbein, M. [1 ]
Lynch, J. P., III [1 ]
Elashoff, R. M. [1 ]
Belperio, J. A. [1 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4011
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Evidence of direct interactions between the CC-chemokines CCL3, CCL4 and CCL5 and Leishmania promastigotes
    Roychoudhury, Kaushik
    Dasgupta, Biplab
    Sen, Pradip
    Laskay, Tamas
    Solbach, Werner
    De, Tripti
    Roy, Syamal
    MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2006, 150 (02) : 374 - 377
  • [22] Ragweed-allergic subjects have decreased serum levels of chemokines CCL2, CCL3, CCL4 and CCL5 out of the pollen season
    Kostova, Zhivka
    Batsalova, Tsvetelina
    Moten, Dzhemal
    Teneva, Ivanka
    Dzhambazov, Balik
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2015, 40 (04) : 442 - 446
  • [23] CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment
    Bandinelli, F.
    Del Rosso, A.
    Gabrielli, A.
    Giacomelli, R.
    Bartoli, F.
    Guiducci, S.
    Matucci-Cerinic, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (02) : S44 - S49
  • [24] CCL2 and CCL5 as new markers of early-stage endometrial cancer
    Bedkowska, E. G.
    Gacuta, E.
    Lawicki, S.
    Motyka, J.
    Kicman, A.
    Kulesza, M.
    Pankowska, K.
    Lawicki, P.
    Chlabicz, M.
    Dabrowska, M.
    CLINICA CHIMICA ACTA, 2022, 530 : S70 - S71
  • [25] The CCL2 and CCL5 chemokine levels in serum of multiple sclerosis patients during relapse
    Bartosik-Psujek, H
    Stelmasiak, Z
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S169 - S169
  • [26] Stage dependent increase of CCL2 and CCL5 in peripheral blood of colorectal cancer patients
    Laubli, Heinz Philipp
    Spanaus, Katharina-Susanne
    Zippelius, Alfred
    Borsig, Lubor
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [27] CCL2 and CCL5 Are Novel Therapeutic Targets for Estrogen-Dependent Breast Cancer
    Svensson, Susanne
    Abrahamsson, Annelie
    Rodriguez, Gabriela Vazquez
    Olsson, Anna-Karin
    Jensen, Lasse
    Cao, Yihai
    Dabrosin, Charlotta
    CLINICAL CANCER RESEARCH, 2015, 21 (16) : 3794 - 3805
  • [28] Suppression of CCL2/MCP-1 and CCL5/RANTES expression by nociceptin in human monocytes
    Kaminsky, David E.
    Rogers, Thomas J.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2008, 3 (02) : 75 - 82
  • [29] Chemokines CCL2, CCL3, CXCL5, and CXCL5 in haemorrhagic stroke
    Zaremba, J.
    Losy, J.
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 222 (1-2) : 17 - 17
  • [30] Suppression of CCL2/MCP-1 and CCL5/RANTES Expression by Nociceptin in Human Monocytes
    David E. Kaminsky
    Thomas J. Rogers
    Journal of Neuroimmune Pharmacology, 2008, 3 : 75 - 82
12345